Current Clinical Trials

Current Clinical Trials

Currently we are conducting the following Clinical Trial(s):

  1. Idiopathic Hypersomnia Clinical Trial: Patients ages 18-55, with Idiopathic Hypersomnia. This study is looking at the effect of a new medicine on sleepiness in patients with Idiopathic Hypersomnia who have access to their previous test results confirming Idiopathic Hypersomnia. It lasts 10 weeks, with up to five 24 hour stays with us as well as two other visits. We pay up to $2000 for the subject’s time and expenses.

Clinical trials come and go, and they fill up fast.

How do I participate?

Call our office at 586-254-0707, or fill out a request for us to contact you.

New medicine for daytime sleepiness

A new medicine for daytime sleepiness was approved this year. It should arrive in pharmacies in the next few months. Its name is SunosiR (or solriamfetol). It blocks reuptake of dopamine (DA) and norepinephrine (NE) into nerve cells that release these. As a result, DA and NE levels increase in the area between nerve cells…

CPAP Adherence and How to Improve It

Continuous Positive Airway Pressure (CPAP) is the best treatment for obstructive sleep apnea (OSA). Unfortunately, only 59% of patients prescribed CPAP in the USA actually use it. Yet, being adherent to CPAP use is crucial in controlling OSA and its complications. The complications include sleepiness and fatigue, memory and concentration problems, high blood pressure, atrial…

Sleeping with half the brain

Sleeping with half the brain – is that even possible? Yes, it is. Many birds and aquatic mammals sleep with half the brain at any time, according to Scientific American (June 2019) [https://www.scientificamerican.com/magazine/sa/2019/06-01/?redirect=1] Mammals that live in water (whales, dolphins, porpoises) might drown if they fall asleep. They cannot breathe when under water. Therefore, they…

Schedule An Appointment Today

44344 Dequindre Rd Suite 360
Sterling Heights, MI 48314
click here for directions